BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of $17.25 billion. The enterprise value is $15.52 billion.
Market Cap | 17.25B |
Enterprise Value | 15.52B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, before market open.
Earnings Date | Jul 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BeiGene has 111.51 million shares outstanding.
Shares Outstanding | 111.51M |
Owned by Insiders (%) | 19.56% |
Owned by Institutions (%) | 49.13% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.25 |
Forward PS | 1.04 |
PB Ratio | 5.13 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.62 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.32.
Current Ratio | 2.08 |
Quick Ratio | 1.72 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 10.88 |
Financial Efficiency
Return on equity (ROE) is -21.70% and return on invested capital (ROIC) is -24.82%.
Return on Equity (ROE) | -21.70% |
Return on Assets (ROA) | -13.80% |
Return on Capital (ROIC) | -24.82% |
Revenue Per Employee | $260,625 |
Profits Per Employee | -$74,003 |
Employee Count | 10,600 |
Asset Turnover | 0.49 |
Inventory Turnover | 1.14 |
Taxes
In the past 12 months, BeiGene has paid $52.10 million in taxes.
Income Tax | 52.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.89% in the last 52 weeks. The beta is 0.59, so BeiGene's price volatility has been lower than the market average.
Beta (5Y) | 0.59 |
52-Week Price Change | -19.89% |
50-Day Moving Average | 155.82 |
200-Day Moving Average | 164.17 |
Relative Strength Index (RSI) | 54.33 |
Average Volume (20 Days) | 262,894 |
Short Selling Information
Short Interest | 1.67M |
Short Previous Month | 1.83M |
Short % of Shares Out | 5.88% |
Short % of Float | n/a |
Short Ratio (days to cover) | 8.68 |
Income Statement
In the last 12 months, BeiGene had revenue of $2.76 billion and -$784.43 million in losses. Loss per share was -$0.59.
Revenue | 2.76B |
Gross Profit | 2.34B |
Operating Income | -1.10B |
Pretax Income | -732.32M |
Net Income | -784.43M |
EBITDA | -713.52M |
EBIT | -806.48M |
Loss Per Share | -$0.59 |
Balance Sheet
The company has $2.79 billion in cash and $1.06 billion in debt, giving a net cash position of $1.73 billion or $15.52 per share.
Cash & Cash Equivalents | 2.79B |
Total Debt | 1.06B |
Net Cash | 1.73B |
Net Cash Per Share | $15.52 |
Equity (Book Value) | 3.36B |
Book Value Per Share | 30.14 |
Working Capital | 2.03B |
Cash Flow
In the last 12 months, operating cash flow was -$902.25 million and capital expenditures -$597.56 million, giving a free cash flow of -$1.50 billion.
Operating Cash Flow | -902.25M |
Capital Expenditures | -597.56M |
Free Cash Flow | -1.50B |
FCF Per Share | -$14.39 |
Margins
Gross margin is 84.69%, with operating and profit margins of -39.74% and -28.39%.
Gross Margin | 84.69% |
Operating Margin | -39.74% |
Pretax Margin | -26.51% |
Profit Margin | -28.39% |
EBITDA Margin | -25.83% |
EBIT Margin | -29.19% |
FCF Margin | -54.29% |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.10% |
Shareholder Yield | -0.10% |
Earnings Yield | -4.55% |
FCF Yield | -8.69% |
Analyst Forecast
The average price target for BeiGene is $254.85, which is 64.70% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $254.85 |
Price Target Difference | 64.70% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 84.05% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.91 |
Piotroski F-Score | 3 |